logo
  

Simpsons Q2 Earnings Rises, But Misses Estimates

California-based constructions company Simpson Manufacturing Co., Inc. (SSD), reported better earnings year-over-year in the third quarter, however, fell short of Street estimates.

Simpson reported a net income of $73.78 million or $1.70 earnings per share compared to $67.05 million or $1.54 earnings per share last year. On average, four analysts polled by Thomson Reuters forecast earnings of $1.77 per share for the quarter.

The revenue reported by the company also increased 9% to $396.70 million from $364.30 million. The analysts expected revenue of $447.79 million for the quarter.

The board of directors of the company announced a cash dividend of $0.25 per share on January 27 to investors on record on January 6.

Karen Colonias, president and CEO of the company, said, "During the third quarter, we experienced lighter sales volumes in North America in the distribution channels we serve. We believe our customers are adopting a more cautious stance in regard to their inventory levels given tightening labor and supply chain conditions and the potential impact on the building industry. Sales volumes also reflected an as expected decline year-over-year in our home center channel related to the load-in of our products at Lowe's during the third quarter of 2020 following their return as a home center customer."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Shares of LM Ericsson were gaining more than 7 percent in Swedish trading as well as in pre-market activity on Nasdaq, after the telecom equipment maker reported Tuesday higher profit and sales in its fourth quarter with strong demand. Further, the company lifted its full-year dividend, and maintained targets for fiscal 2022 EBIT growth as well as long-term target of EBITA margin. Twitter Inc. said it is expanding engineering center in Singapore, its Asia Pacific headquarters. The number of engineers there will be doubled to over 100 staff in 2023. Focused on product innovations and improvements, the new hires will work from Singapore on global initiatives for Twitter. These new technical hires will span roles in engineering, data science, machine learning and product... The U.S. Food and Drug Administration (FDA) has granted approval and reissued the revised Emergency Use Authorization (EUA) to Gilead Sciences Inc. for antiviral drug Veklury (remdesivir) to treat certain non-hospitalized adults and pediatric patients with mild-to-moderate COVID-19 disease.
RELATED NEWS
Follow RTT